Home › Trial NCT02689921
NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer
- Trial IDNCT02689921
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorMidwestern Regional Medical Center
- Enrollment7
- Start date2016-04
- ConditionsBreast Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.